// App-Quantinova.ai

P2-01-06 : Association between Circulating Tumor Cells and Bone Turnover Markers in Patients with Breast Cancer and Bone Metastases on Treatment with Bisphosphonates (ZOMAR Study)

Researchers

Presenter

  • Manso L

Principal Investigators

  • Tusquets I

  • Margel M

  • Murias A

  • Salvador J

  • Segui MA

  • De Juan A

  • Gavila J

  • Luque M

  • Perez D

  • Zamora P

  • Crespo C

  • Gomez P

  • Calvo L

  • Ruiz M

  • Martinez P

  • Perello A

  • Anton A

  • Codes M

Medical Centers

  • Hospital Marques de Valdecilla, Santander, Spain

  • Hospital Parc Tauli Sabadell, Sabadell, Spain

  • Hospital Doce de Octubre, Madrid, Spain

  • Hospital Virgen de la Salud, Toledo, Spain

  • Hospital Universitario Ramon y Cajal, Madrid, Spain

  • Hospital Palencia Rio Carrion, Palencia, Spain

  • Hospital Central de Asturias, Oviedo, Spain

  • Pharmacy, Hospital Virgen Macarena, Sevilla, Spain

  • Hospital Cruz Roja Hospitalet del Llobregat, Barcelona, Spain

  • Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz, Madrid, Spain

  • Hospital Miguel Servet, Zaragoza, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bone metastases

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N-terminal telopeptide

  • Bone specific alkaline phosphatase

  • Circulating tumor cells

Drug/Treatment

  • Alkaline phosphatase

  • Zoledronic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved